Cyclic AMP as a mediator of prostaglandin E-induced suppression of human natural killer cell activity.

Tetsuhisa Goto, R B Herberman, A E Maluish, +1

The Journal of Immunology

ApoptosisImmunologyImmunologic MechanismProstaglandin E-induced SuppressionImmunotherapy +17

A Multiple-Dose Phase I Trial of Recombinant Leukocyte A Interferon in Cancer Patients

Stephen A. Sherwin, James A. Knost, Seymour Fein, +6

JAMA

ImmunologyPathologyCancer PatientsBiological ResponseImmunotherapy +14

The determination of an immunologically active dose of interferon-gamma in patients with melanoma.

A E Maluish, Walter J. Urba, Daniele Longo, +7

Journal of Clinical Oncology

ImmunodeficienciesImmunologyImmunoeditingPathologyActive Dose +17

Detection of Anti-tumour Cell Mediated Immunity and Serum Blocking Factors in Cancer Patients by the Leucocyte Adherence Inhibition Test

W.J. Halliday, A E Maluish, William H. Isbister

British Journal of Cancer

Cancer ImmunosurveillanceSerum Blocking FactorsMedicineImmunologyTumor Immunity +8

Depression of natural killer cytotoxicity after in vivo administration of recombinant leukocyte interferon.

A E Maluish, John R. Ortaldo, John Conlon, +6

The Journal of Immunology

A phase I trial of recombinant gamma interferon in patients with cancer

KennethA. Foon, StephenA. Sherwin, PaulG. Abrams, +5

Cancer Immunology Immunotherapy

Recombinant Gamma InterferonMedicineImmunologyCancer TreatmentRadiation Oncology +4

Hyporesponsiveness to augmentation of murine natural killer cell activity in different anatomical compartments by multiple injections of various immunomodulators including recombinant interferons and interleukin 2.

James E. Talmadge, R B Herberman, M. A. Chirigos, +7

The Journal of Immunology

Lymphocyte subset distribution and natural killer activity in growth hormone deficiency before and during short-term treatment with growth hormone releasing hormone

Saúl Malozowski, Marie C. Gelato, O. Butenand, +5

Clinical Immunology and Immunopathology

Growth HormoneHuman GrowthGrowth Hormone DeficiencyImmunologyDevelopmental Endocrinology +3

Immunomodulatory properties and toxicity of interleukin 2 in patients with cancer.

W J Urba, Ronald G. Steis, Dan L. Longo, +6

PubMed

InflammationCytokineCancer ImmunosurveillanceInterleukin 2Immunotoxicology +13

Alterations in cytotoxic and helper T cell function after infection of T cell clones with human T cell leukemia virus, type I.

Robert Yarchoan, H.-G. Guo, M S Reitz, +3

Journal of Clinical Investigation

T Cell ClonesAutoimmune DiseaseHtlv-i InfectionAdaptive Immune SystemHuman Retrovirus +10